相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The impact of selenium on regulatory T cell frequency and immune checkpoint receptor expression in patients with diffuse large B cell lymphoma (DLBCL)
Mehdi Dehghani et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Evaluation of regulatory T cells frequency and FoxP3/GDF-15 gene expression in β-thalassemia major patients with and without alloantibody; correlation with serum ferritin and folate levels
Negin Shokrgozar et al.
ANNALS OF HEMATOLOGY (2020)
Challenges of blood transfusions in β-thalassemia
Farrukh T. Shah et al.
BLOOD REVIEWS (2019)
LAG-3 antagonists by cancer treatment: a patent review
Martin Perez-Santos et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
Regulatory T Cells: the Many Faces of Foxp3
Peter Georgiev et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2019)
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Shuang Qin et al.
MOLECULAR CANCER (2019)
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, efficacy, and Limitations
Judith A. Seidel et al.
FRONTIERS IN ONCOLOGY (2018)
How I manage medical complications of β-thalassemia in adults
Ali T. Taher et al.
BLOOD (2018)
Regulatory T cells in cancer immunotherapy
Atsushi Tanaka et al.
CELL RESEARCH (2017)
Characterization of circulating CD4+ CD8+ double positive and CD4- CD8- double negative T-lymphocyte in children with β-thalassemia major
Asmaa M. Zahran et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint
Vincenzo De Sanctis et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2017)
The regulation of immune tolerance by FOXP3
Ling Lu et al.
NATURE REVIEWS IMMUNOLOGY (2017)
CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition
Elizabeth I. Buchbinder et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
Tim-3: Expression on immune cells and roles at the maternal-fetal interface
Xiao-Hui Hu et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2016)
Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt
Abeer Mohamed Abdelrazik et al.
TRANSFUSION (2016)
Understanding red blood cell alloimmunization triggers
Jeanne E. Hendrickson et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
Inhibitory receptors as targets for cancer immunotherapy
Meghan E. Turnis et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Identification of genetic polymorphisms that predict responder/non-responder profiles to the RhD antigen
Joanne C. G. Tan et al.
MOLECULAR IMMUNOLOGY (2015)
A Genome-Wide Screen for Large-Effect Alloimmunization Susceptibility Loci among Red Blood Cell Transfusion Recipients with Sickle Cell Disease
Neil A. Hanchard et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2014)
Molecular Pathways: Coexpression of Immune Checkpoint Molecules: Signaling Pathways and Implications for Cancer Immunotherapy
Christopher J. Nirschl et al.
CLINICAL CANCER RESEARCH (2013)
LAG-3 Expression Defines a Subset of CD4+CD25highFoxp3+ Regulatory T Cells That Are Expanded at Tumor Sites
Chiara Camisaschi et al.
JOURNAL OF IMMUNOLOGY (2010)
Beta-thalassemia
Renzo Galanello et al.
ORPHANET JOURNAL OF RARE DISEASES (2010)
Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity
Marjan Gharagozloo et al.
ANNALS OF HEMATOLOGY (2009)
Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice
Weili Bao et al.
BLOOD (2009)
RBC alloimmunization in blood transfusion-dependent β-thalassemia patients in southern Iran
M. Karimi et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2007)
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
C Zhu et al.
NATURE IMMUNOLOGY (2005)
Negative regulation of T cell homeostasisby lymphocyte activation gene-3 (CD223)
CJ Workman et al.
JOURNAL OF IMMUNOLOGY (2005)
Immunological status of thalassemia syndrome
U Ezer et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2002)
分享论文
